Eckert & Ziegler Strahlen- und Medizintechnik AG
Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories… Read more
Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) - Total Liabilities
Latest total liabilities as of September 2025: €218.89 Million EUR
Based on the latest financial reports, Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) has total liabilities worth €218.89 Million EUR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Eckert & Ziegler Strahlen- und Medizintechnik AG - Total Liabilities Trend (2013–2024)
This chart illustrates how Eckert & Ziegler Strahlen- und Medizintechnik AG's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Eckert & Ziegler Strahlen- und Medizintechnik AG Competitors by Total Liabilities
The table below lists competitors of Eckert & Ziegler Strahlen- und Medizintechnik AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hubei Zhongyi Science Technology Co. Ltd.
SHE:301150
|
China | CN¥3.20 Billion |
|
Yijiahe Technology Co Ltd
SHG:603666
|
China | CN¥1.06 Billion |
|
Beijing Utour International Travel Service Co Ltd
SHE:002707
|
China | CN¥2.12 Billion |
|
Liquidity Services Inc
NASDAQ:LQDT
|
USA | $153.88 Million |
|
Adrian Resources Ltd
PINK:ADLRF
|
USA | $178.51 Million |
|
Southern Publishing&Media Co
SHG:601900
|
China | CN¥8.98 Billion |
|
NioCorp Developments Ltd. Common Stock
NASDAQ:NB
|
USA | $39.97 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down Eckert & Ziegler Strahlen- und Medizintechnik AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.93 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.95 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.48 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Eckert & Ziegler Strahlen- und Medizintechnik AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Eckert & Ziegler Strahlen- und Medizintechnik AG (2013–2024)
The table below shows the annual total liabilities of Eckert & Ziegler Strahlen- und Medizintechnik AG from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €217.18 Million | +0.89% |
| 2023-12-31 | €215.27 Million | +5.94% |
| 2022-12-31 | €203.21 Million | +30.93% |
| 2021-12-31 | €155.20 Million | +8.47% |
| 2020-12-31 | €143.08 Million | +6.15% |
| 2019-12-31 | €134.79 Million | +28.16% |
| 2018-12-31 | €105.17 Million | +5.73% |
| 2017-12-31 | €99.47 Million | +11.28% |
| 2016-12-31 | €89.39 Million | -2.85% |
| 2015-12-31 | €92.01 Million | -0.90% |
| 2014-12-31 | €92.84 Million | +5.33% |
| 2013-12-31 | €88.14 Million | -- |